Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Oxygen signs CRADA with U.S. navy to study decompression sickness therapy

Aug. 4, 2010

Seattle Genetics and Genentech expand antibody-drug conjugate agreement

Aug. 4, 2010

Lexicon reacquires rights to several serotonin synthesis inhibitors from Symphony Icon

Aug. 4, 2010

Cornerstone and Alitair collaborate on drug development for respiratory diseases

Aug. 4, 2010

Servier to develop and commercialize Osteologix's NBS-101 outside U.S.

Aug. 3, 2010

Stellar Pharma and Inibsa sign agreement to distribute and sell Uracyst in Spain

Aug. 2, 2010

Actient Pharmaceuticals acquires six pharmaceuticals from UCB

Aug. 2, 2010

National Eye Institute awards Lpath grant to develop sonepcizumab for wet AMD

Aug. 2, 2010

Daiichi Sankyo and Kitasato Institute to form joint venture company

Aug. 2, 2010

Charles River Laboratories and WuXi PharmaTech terminate acquisition agreement

Aug. 2, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...